Global Bio-chem Technology Group Co. Ltd.(HK:0809)
HK$0.33-0.01 (-1.52%)
HK:0809
Global Bio-chem Technology Group Co. Ltd. financials statements
HK$0.33
At close:-0.01 (-1.52%)
Want to see HK:0809 full AI Analyst Report?
Global Bio-chem Technology Group Co. Ltd. (0809) Ratios
0 Followers
Global Bio-chem Technology Group Co. Ltd. Ratios
HK:0809's free cash flow for Q2 2026 was HK$23.19M. For the 2026 fiscal year, HK:0809's free cash flow was decreased by HK$-16.25M and operating cash flow was HK$39.44M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.49 | 0.32 | 0.12 | 0.05 | 0.05 |
| Quick Ratio | 0.48 | 0.29 | 0.10 | 0.03 | 0.04 |
| Cash Ratio | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 |
| Solvency Ratio | 0.05 | 0.16 | 0.48 | -0.09 | 0.00 |
| Operating Cash Flow Ratio | -0.00 | 0.01 | -0.01 | -0.01 | -0.04 |
| Short-Term Operating Cash Flow Coverage | -0.01 | 0.02 | -0.01 | -0.01 | -0.06 |
| Net Current Asset Value | HK$ -2.89B | HK$ -4.40B | HK$ -8.28B | HK$ -12.95B | HK$ -12.59B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.39 | 0.81 | 1.05 | 1.52 | 1.30 |
| Debt-to-Equity Ratio | -3.46 | -1.89 | -1.35 | -1.18 | -1.30 |
| Debt-to-Capital Ratio | 1.41 | 2.13 | 3.86 | 6.50 | 4.38 |
| Long-Term Debt-to-Capital Ratio | 13.47 | 0.00 | -0.25 | 0.00 | -0.17 |
| Financial Leverage Ratio | -8.91 | -2.32 | -1.29 | -0.78 | -0.99 |
| Debt Service Coverage Ratio | 0.37 | 0.01 | 0.88 | -0.04 | 0.09 |
| Interest Coverage Ratio | -0.25 | -0.43 | -0.42 | -0.39 | -0.47 |
| Debt to Market Cap | 2.55 | 3.90 | 5.77 | 6.41 | 7.64 |
| Interest Debt Per Share | 1.94 | 4.50 | 0.70 | 1.08 | 1.04 |
| Net Debt to EBITDA | 2.94 | 213.94 | 1.14 | -18.91 | 10.72 |
| Profitability Margins | |||||
| Gross Profit Margin | 8.62% | 10.93% | 3.18% | -2072.02% | 6.48% |
| EBIT Margin | 20.39% | -13.30% | 323.99% | -5819.90% | 51.32% |
| EBITDA Margin | 25.37% | 0.84% | 341.59% | -3690.22% | 105.24% |
| Operating Profit Margin | -3.45% | -6.98% | -23.16% | -2122.93% | -49.67% |
| Pretax Profit Margin | 6.86% | 37.26% | 269.37% | -11210.34% | -54.85% |
| Net Profit Margin | 6.86% | 38.46% | 307.48% | -11352.91% | -53.69% |
| Continuous Operations Profit Margin | 6.86% | 38.46% | 272.44% | -10842.25% | -58.32% |
| Net Income Per EBT | 99.93% | 103.22% | 114.15% | 101.27% | 97.88% |
| EBT Per EBIT | -199.14% | -533.58% | -1163.24% | 528.06% | 110.43% |
| Return on Assets (ROA) | 3.38% | 16.94% | 81.10% | -24.67% | -6.18% |
| Return on Equity (ROE) | -30.14% | -39.38% | -104.65% | 19.14% | 6.15% |
| Return on Capital Employed (ROCE) | -154.29% | 7.19% | 9.98% | 3.52% | 6.68% |
| Return on Invested Capital (ROIC) | -6.11% | -8.00% | -21.92% | -20.82% | -19.01% |
| Return on Tangible Assets | 3.39% | 16.95% | 81.13% | -24.68% | -6.19% |
| Earnings Yield | 22.23% | 81.32% | 447.43% | -103.85% | -36.29% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.13 | 1.16 | 3.47 | 0.05 | 1.68 |
| Payables Turnover | 1.81 | 1.52 | 1.47 | 0.28 | 0.60 |
| Inventory Turnover | 46.41 | 8.67 | 8.97 | 1.56 | 8.58 |
| Fixed Asset Turnover | 0.97 | 0.83 | 0.33 | 0.00 | 0.13 |
| Asset Turnover | 0.49 | 0.44 | 0.26 | 0.00 | 0.12 |
| Working Capital Turnover Ratio | -0.68 | -0.34 | -0.14 | -0.00 | -0.07 |
| Cash Conversion Cycle | 129.10 | 115.63 | -102.20 | 6955.79 | -353.58 |
| Days of Sales Outstanding | 322.37 | 314.09 | 105.19 | 8020.27 | 216.63 |
| Days of Inventory Outstanding | 7.87 | 42.08 | 40.70 | 234.25 | 42.56 |
| Days of Payables Outstanding | 201.14 | 240.54 | 248.08 | 1298.73 | 612.77 |
| Operating Cycle | 330.24 | 356.17 | 145.88 | 8254.52 | 259.19 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | 0.09 | -0.01 | -0.01 | -0.05 |
| Free Cash Flow Per Share | -0.03 | 0.09 | -0.01 | -0.01 | -0.06 |
| Dividend Paid and CapEx Coverage Ratio | -0.35 | 0.00 | -1.15 | -14.25 | -18.41 |
| Capital Expenditure Coverage Ratio | -0.35 | 0.00 | -1.15 | -14.25 | -18.41 |
| Operating Cash Flow Coverage Ratio | -0.00 | 0.02 | -0.01 | -0.01 | -0.06 |
| Operating Cash Flow to Sales Ratio | -0.00 | 0.04 | -0.04 | -6.92 | -0.64 |
| Free Cash Flow Yield | -4.04% | 8.03% | -9.98% | -6.78% | -45.36% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 4.64 | 1.23 | 0.22 | -0.96 | -2.76 |
| Price-to-Sales (P/S) Ratio | 0.31 | 0.47 | 0.69 | 109.32 | 1.48 |
| Price-to-Book (P/B) Ratio | -1.36 | -0.48 | -0.23 | -0.18 | -0.17 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -24.77 | 12.45 | -10.02 | -14.75 | -2.20 |
| Price-to-Operating Cash Flow Ratio | -95.66 | 12.45 | -18.71 | -15.79 | -2.32 |
| Price-to-Earnings Growth (PEG) Ratio | -0.06 | -0.02 | -0.00 | -0.00 | 0.03 |
| Enterprise Value Multiple | 4.16 | 270.10 | 1.34 | -21.87 | 12.13 |
| Enterprise Value | 2.40B | 4.55B | 6.31B | 10.26B | 9.53B |
| EV to EBITDA | 4.16 | 270.10 | 1.34 | -21.87 | 12.13 |
| EV to Sales | 1.05 | 2.27 | 4.59 | 807.02 | 12.76 |
| EV to Free Cash Flow | -84.61 | 59.86 | -66.91 | -108.91 | -19.02 |
| EV to Operating Cash Flow | -326.80 | 59.86 | -124.96 | -116.56 | -20.05 |
| Tangible Book Value Per Share | -0.48 | -2.19 | -0.45 | -0.87 | -0.75 |
| Shareholders’ Equity Per Share | -0.48 | -2.19 | -0.45 | -0.85 | -0.73 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.03 | -0.01 | 0.03 | -0.06 |
| Revenue Per Share | 2.11 | 2.24 | 0.15 | 0.00 | 0.08 |
| Net Income Per Share | 0.14 | 0.86 | 0.47 | -0.16 | -0.04 |
| Tax Burden | 1.00 | 1.03 | 1.14 | 1.01 | 0.98 |
| Interest Burden | 0.34 | -2.80 | 0.83 | 1.93 | -1.07 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.80 | 0.02 |
| SG&A to Revenue | 0.13 | 0.18 | 0.22 | 25.82 | 0.50 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.05 | 0.10 | -0.01 | 0.06 | 1.16 |
Currency in HKD
